Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-894P is a processed pseudogene related to U6 small nuclear RNA, a core component of the spliceosome essential for pre-mRNA splicing in eukaryotes[1][3]. Unlike functional U6 snRNA, RNU6-894P does not produce a functional RNA product and is generally considered biologically inactive. Most pseudogenes, including those derived from snRNAs, do not encode functional molecules but may occasionally exert regulatory effects by acting as decoys for microRNAs or other regulatory factors[2]. RNU6-894P, however, has no specific documented biological or clinical significance. If you require structured information for a functional U6 snRNA (not the pseudogene), note that the canonical name would be "U6 small nuclear RNA," which is deeply involved in spliceosomal assembly and function[1][3].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 894, pseudogene (RNU6-894P).